STENTIT is a Dutch-based start-up which develops regenerative stents – stents that, once implanted in patients with cardiovascular diseases, can hold blood vessels open while healing them. STENTiT is now focusing on the first therapeutic application – the treatment of atherosclerosis in patients at risk of amputation. 

Mibiton Solo financing is used to fully equip STENTiT’s R&D facilities.